# FDA Inspection 1065837 - Adam S. Giermasz, M.D., Ph.D. - August 16, 2018

Source: https://www.keypedia.com/records/fda_inspections/adam-s-giermasz-md-phd/d534c48e-ee30-42ee-b20c-6cfbf35eadb8
Source feed: FDA_Inspections

> FDA Inspection 1065837 for Adam S. Giermasz, M.D., Ph.D. on August 16, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1065837
- Company Name: Adam S. Giermasz, M.D., Ph.D.
- Inspection Date: 2018-08-16
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1125668 - 2020-07-17](https://www.keypedia.com/records/fda_inspections/adam-s-giermasz-md-phd/b2111331-6fdc-4ab9-9d17-aeac053d0d0f)
- [FDA Inspection 1125668 - 2020-07-17](https://www.keypedia.com/records/fda_inspections/adam-s-giermasz-md-phd/e0f24201-4bce-4322-a7d0-8ee93a80518a)

Company: https://www.keypedia.com/companies/adam-s-giermasz-md-phd/bcc67ec3-cb56-4ad3-a4db-8ec362cceff5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c